Hexagon Nutrition made its market debut today, listing at Rs. 48 against the discovered price of Rs. 45, implying a modest listing premium of around 6.7%. The issue saw strong demand, with overall subscription at 53.68x, led by HNI subscription of 161.49x, retail at 26.85x and QIB at 19.77x.

Hexagon Nutrition is a 33-year-old Mumbai-based nutrition products company operating across three segments. Its largest business is B2B2C, contributing around 50% of revenue, where it supplies vitamin and mineral premixes to Indian and multinational FMCG companies. The B2C segment, which contributes around 30%, includes branded wellness and clinical nutrition products such as PentaSure, ObesiGo, PediaGold and NutrOne, sold through doctor networks and online platforms such as Amazon and Flipkart. The ESG-linked business contributes the remaining 20%, mainly through ready-to-use therapeutic food and micronutrient powders under UN-linked public health and food-fortification programmes.

The market response is best read as a short-term demand-led listing rather than a major re-rating. Subscription was healthy, especially from the HNI category, and the company has a diversified nutrition portfolio across institutional, consumer and global public-health channels. However, the listing premium itself was not very large, which suggests the market is acknowledging the growth story but not yet assigning a strong long-term premium.

Our IPO view remains unchanged. We had recommended the IPO only for investors with a short-term view, while the long-term case needs monitoring over the next few quarters.